Interested in sponsoring an event? Please click here to let us know which event(s) you are interested in and we will be happy to contact you with your personalized sponsorship opportunities!
Speakers from the FDA will explain what the safety concerns are for sunscreen formulations, the testing that will be required by the FDA to determine sunscreen products are
Speakers from the FDA will explain what the safety concerns are for sunscreen formulations, the testing that will be required by the FDA to determine sunscreen products are “Generally Regarded as Safe and Effective” for human use. Other speakers will discuss the impact the new regulations will have on testing labs, industry and a blogger will present the impact on the consumer.
At Door Cost
|Students / Unemployed||
4:00-4:10 PM Welcome and Introduction
4:10-4:35 PM Dr. Raney
4:35-5:00 PM Dr. Bashaw
5:00- 5:25 PM Dr. Stinchcomb
5:25-5:50 PM Dr. Yi
5:50-6:20 PM Break/Cocktail Hour
6:20- 6:45PM Dr. Caswell
6:45- 7:05 PM Dr. Kowcz
7:05- 8:00 PM Dinner
7:15 – 8:00 PM Dinner speakers: Mr. Berkland and Ms. Espinoza
Dr. E. Dennis Bashaw, Pharm.D
Presentation Title: A History of Dermal Absorption Assessment at the FDA
Although it has a long history in the occupational safety arena, the dermal absorption of topically applied substances has been a relative late-comer to pharmaceutics and drug evaluation. This was primarily due to the limitations in analytical methods that were only overcome in the mid-1990s. Since that the time US Food and Drug Administration (FDA) has been requiring of all NDA applications the submission of in vivo absorption data under the “maximal” conditions of use as used in the clinical trials program and anticipated in labeling. Since its establishment as a requirement the FDA has evaluated over 50 Maximal Usage Trials or MUsT, the results of which informed both the pharmacology and toxicology evaluation and labeling.
This presentation will present a history of the assessment of dermal absorption, the underpinnings of the Maximal Usage Trial, a discussion of the recent experience of the FDA in the assessment of OTC sunscreens, and the incorporation of the MUsT methodology into the ongoing Sunscreen Monograph evaluation.
Senior Science Advisor to the Office of Clinical Pharmacology
Division of Clinical Pharmacology-3
US Food and Drug Administration.
Dr. Bashaw received his BS in Pharmacy and Doctor of Pharmacy from the University of Kentucky in 1986. Upon completion of a residency at the National Institutes of Health-Clinical Center, Dr. Bashaw accepted a commission in the United States Public Health Service as a reviewer in the then Division of Biopharmaceutics. In his 32 yrs at the FDA he has been a primary reviewer, team leader, deputy division director and division director across a number of therapeutic areas including, but not limited to neuropharmacology, surgical drugs, anti-inflammatory, over-the-counter, and pulmonary drugs in addition to his current responsibilities.
He was appointed the Director of the Division of Clinical Pharmacology-3 (DCP-3) in March 2006. As the Director of DCP-3, Dr. Bashaw oversaw the work of 26 PhDs. and PharmDs supporting the review of drugs in the reproductive-urologic, gastrointestinal and dermatologic areas. He held that position until Dec 2017 when he retired from the US Public Health Service with 30yrs of service. While a Commissioned Officer at the FDA, Dr. Bashaw received over 30 awards for performance and/or scientific merit, including the Public Health Service Meritorious Service Medal which was given for scientific excellence. This is the second highest award a PHS Officer can receive.
In May 2018 Dr. Bashaw returned to the FDA as the Senior Science Advisor to the Office of Clinical Pharmacology. In this position he primarily over sees the activities related to the assessment of dermal absorption with regards to antiseptics and sunscreens, in addition he is the Office representative on a number of cross Office working groups including nanotechnology and orphan diseases. He is a highly regarded and internationally recognized expert in these areas and has published widely and has represented the FDA internationally as an invited speaker.
Dr. Sejeong Yi
In Vitro Skin Permeation Test (IVPT) Coupled with Maximal Use Trial (MUsT) to Assess Dermal Absorption of Topical OTC Products
Any unwanted systemic exposure to topical products potentially have safety concerns. To address dermal absorption of active ingredients, the FDA has required maximal use trials (MUsT) as a part of safety evaluation for some topical OTC products such as sunscreens and topical antiseptics that are chronically used. As there are potential formulation effects on dermal absorption of an active ingredient, the in vitro skin permeation test (IVPT) should be used to inform formulation selection for a MUsT program and to address formulation effects of OTC products on dermal absorption. However, many in vitro skin permeation studies have produced results with high variability and low reproducibility. In order for the IVPT to be used for the OTC regulatory purpose, the IVPT needs to be adequately validated considering some important elements of the IVPT.
Dr. Sojeong Yi is a clinical pharmacology reviewer responsible for OTC topical antiseptics and sunscreens as well as gastroenterology drug products in the Office of Clinical Pharmacology, FDA. Since she joined FDA in 2016, she has actively been involving in publishing proposed rules and final rules of topical antiseptic monographs and providing regulatory and scientific guidance on MUsT programs of OTC topical antiseptics. Prior to joining FDA, she worked as a research fellow in Clinical Pharmacology Unit of Seoul National University Hospital. She earned a PhD and MS degree in Clinical Pharmacology in Seoul National University and B.S. degree in Pharmacy in Ewha Women’s University in South Korea.
Dr. Audra Stinchcomb
Presentation Title: Environmental Harmonization in Multi-Application Sunscreen Use: In Vitro Permeation Testing to Healthy Volunteers
Exposure to heat has resulted in increased oxybenzone flux and cumulative skin permeation from some sunscreen products tested in vitro. Based on these results, we designed healthy human volunteer studies in order to evaluate the rate and extent of oxybenzone absorption in vivo with 8 h of heat application, as compared to baseline skin temperature conditions. The human pharmacokinetic studies were done using a streamlined mini-maximal usage trial (MUsT) design, a miniMUsT. We hypothesize that with frequent sunscreen reapplication and high summer temperatures and humidities, adults and children may be unintentionally exposed to higher concentrations of systemic oxybenzone (and other UV filters). The miniMUsT design allows marketed products and novel sunscreen formulations to be compared in a crossover fashion, prior to implementation of the required MUsT design. Our goal is to establish an in vitro/in vivo correlation for oxybenzone absorption. Optimized in vitro studies may help to decrease the number of clinical trials required for UV filter product testing.
Dr. Stinchcomb is Professor of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore. She is also currently the Chief Scientific Officer and Co-Founder of F6 Pharma Inc., a palliative care product company. She received her Bachelor’s in Pharmacy from the University of Colorado, and a PhD in Pharmaceutics from the University of Michigan. She completed a postdoctoral fellowship at UCSF. She was a Professor at the University of Kentucky from 2001-11, and joined the faculty at UMB in November 2011. She is a Fellow of the American Association of Pharmaceutical Scientists. Dr. Stinchcomb’s research interests span across many disciplines, including pharmaceutics, drug delivery, medicinal chemistry, neuroscience, dermatology, bioengineering, regulatory science, and translational research models.
Dr. Mike Caswell
Title: Old and New Methodologies for SPF testing and Data Validity of Each
Three older SPF test methodologies, Food & Drug Administration Final Monograph, Australia/New Zealand, and COLIPA International, have coalesced into two methodologies, Food & Drug Administration Final Rule and ISO 24444. Data will be presented that indicates that the three older methods gave essentially identical SPF values. Additional data will be presented indicating that the two newer methods also give essentially identical SPF values. Using the additional data, interlaboratory variation will be explored. Lastly, reading and understanding data validity of an SPF test will be reviewed.
Dr. Mike Caswell earned his Ph.D. in biochemistry at the University of North Carolina – Chapel Hill and studied physical organic chemistry at Yale University. After beginning his industrial career at Unilever, he conducted research at Schering-Plough, Body Drench, C.B. Fleet, and three start-up drug companies. Dr. Mike is a Certified Clinical Research Coordinator and a Certified Clinical Research Associate by the Association of Clinical Research Professionals. Currently he is a Principal Investigator at Consumer Product Testing Company, Inc., where he manages the clinical operations.
Dr. Alexandra Kowcz
Current Status of the FDA Final Sunscreen Monograph and Status of the Industry in Response
Alexandra Kowcz is the Chief Scientist for the Personal Care Products Council. Most recently, she served as Vice President of US Research & Development at Beiersdorf, Inc. (manufacturer of Nivea, Eucerin and Aquaphor consumer brands). Her various responsibilities include the management of US product development, medical and scientific affairs, clinical testing, product safety testing, analytical testing, microbiology, regulatory, claims substantiation, chemical processing and new technology research.
She has held a number of R&D positions of increasing responsibility at Procter & Gamble, Bristol Myers International, Richardson-Vicks, Clairol, Inc., Centerchem, Rhone-Poulenc Rorer and Bristol-Myers. Additionally, she is the author and co-author of numerous patents, publications, chapters, and scientific poster presentations. Alexandra has presented at many national and international meetings on technical subjects dealing with formulation chemistry, skin research, competitive intelligence, technological innovation, claims development and chemical processing.
She holds degrees in Biology and Chemistry from Fairfield University and completed her graduate studies at the University of Connecticut. She is an active member of the SCC (Society of Cosmetic Chemists) and the AAD (American Academy of Dermatology).
Mr. Gabriel Berkland
An analysis of the impact the FDA final monograph may have on the sunscreen industry.
The FDA’s much-anticipated final monograph stands to shake up the $2.1B sun care industry in the United States. An estimated 93% of active ingredients in sunscreens currently used in the USA are at risk of being banned due to health concerns. How would a full or partial ban of organic ingredients impact the suppliers, firms, and consumers in the sun care industry? What do consumers ultimately care about when making a sunscreen purchase, and how would the FDA’s decision impact their purchasing decisions? How can suppliers, firms, and consumers be prepared for upcoming changes?
Gabriel works in marketing for EMD Performance Materials, focusing on cosmetics applications. His varied background includes studies in management science (B.S.), accounting, and business (MBA). He started his career in B2C sales, and now is in a business reliant on B2B sales. This holistic perspective allows Gabriel to analyze the sunscreen industry from multiple viewpoints.
How Do Blogs/Vlogs Play A Role in Beauty and what can the industry learn about consumer perception of sunscreen products?
People are looking to the internet for answers regarding beauty and personal care products. Social media enables one to speak directly to the consumer in a unique way that is informal and establishes a personal connection. Consumers have questions on a variety of subjects and consumer products. In my experience roughly half of these questions are related to sun care. A scientific paper is published, and the press may write an article with a brief attention-getting headline. The headline may be sensationalized or oversimplified to attract the attention of readers. It is not uncommon for readers to read the headline without reading the article, or to misinterpret the information contained in the article. In this way, inaccurate information spreads to the general population. This presentation will address such concerns and give examples of common misconceptions consumers have regarding the safety and use of sunscreen products.
Trina Espinoza is a science communicator and the founder of the cosmetic science channel, Ms. Beautyphile. She has spent the last four years sharing the underlying science behind beauty products through a network of social media platforms (FB, YT, Instagram, Twitter: @msbeautyphile). She was featured in Mashable as “6 YouTube channels making learning about science fun”, has been nominated for a regional Emmy, and has made guest appearances on American Chemical Society’s Reactions series. She is currently a Science Advisor to the National Hispanic Heritage Foundation, live streams for In-Cosmetics global, and writes about science for the Seeker digital media network.
Dr. Sam Raney
Presentation Title: A Generic Perspective on the Us of In Vitro Assessment Methods
Dr. Sam Raney is a thought leader in topical and transdermal drug products, with over 25 years of experience producing numerous research manuscripts, review articles, book chapters and patents in pharmaceutical product development. Dr. Raney has been a researcher and adjunct professor within academia, a principal or sub investigator on over 400 pharmaceutical product studies, has held senior management roles in industry, serves as an expert panel member in the U.S. Pharmacopeia., and is the Lead for Topical and Transdermal Drug Products in the FDA Office of Generic Drugs. Dr. Raney holds a Bachelors in Molecular Biophysics & Biochemistry from Yale University, and a Ph.D. in Biochemistry & Molecular Biology from the University of British Columbia in Canada.
(Wednesday) 4:00 PM - 8:00 PM
Delta Hotels Woodbridge
515 US Highway 1 South
Join the LISCC and NYSCC Chapter for a weekend of skiing or boarding. The event is open for the entire family and we will offer one to three days
Join the LISCC and NYSCC Chapter for a weekend of skiing or boarding. The event is open for the entire family and we will offer one to three days of skiing or boarding. We have deeply discounted lift tickets for either; one, two or three days: Friday, February 7; Saturday February 8 and Sunday, February 9. Some people will be traveling after work on Thursday, February 6 and returning the morning of Sunday, February 9. We have added the third day for diehard skiers and boarders who want to get in a few more runs.
On Friday, February 7, the NYSCC will be sponsoring a networking dinner with a speaker. The event will begin with Cocktail Hour at 6pm followed but dinner at 7pm (dinner is open to everyone in attendance). A group rate at Hampton Inn is available for all guests. Transportation is on your own.
Adult Lift Tickets (Ages 19 – 64)
1 Day (Friday) – $55
1 Day (Saturday) – $75
1 Day (Sunday) – $75
2 Days (Friday & Saturday) – $130
Youth, Ages, 7-18 & Senior, Age 65+
1 Day (Friday) – $51
1 Day (Saturday) – $69
1 Day (Sunday) – $69
2 Days (Friday & Saturday) – $119
Rental Equipment rates
1 Day Ski / Snowboard / Helmet – $43 Adult, $31 Youth/Senior
2 Day Ski / Snowboard / Helmet – $74 Adult, $49 Youth / Senior
Lodging at Hampton Inn
SCC has a room rate for $170.00/night and the block is good for 15 rooms.
Dinner on Friday, 2/7
Please notify Vlad by email at email@example.com when registration for lift tickets / rentals is complete.
Questions about skiing and/or boarding, please contact:
Vlad Onyshchak, firstname.lastname@example.org or 631-531-1726
Ina Schlenoff, email@example.com or 631-531-1244
Amy Marshall, firstname.lastname@example.org or 908-391-6294
Impact of FDA monograph on sunscreen formulations; formulating with inorganic sunscreens.
Presented by, Hani Fares, Ph. D.
The proposed rules published by the FDA in the Federal Register in February 2019 had the biggest impact on sunscreen formulations since the publication of the first tentative monograph in August1978. In this presentation, the MUsT (Maximal Usage Trial) study conducted by the FDA that led to the proposed changes will be discussed as well as the impact of those changes on future formulations.
In addition, an in-depth review of formulation strategies with zinc and titanium oxides will be presented. Methodologies used to screen various types of inorganic sunscreens such as zeta potential, contact angle, particle size analysis, SEM microscopy and Hegman gauge will be presented and compared. The effect of particle size on SPF and skin whitening will be discussed. Differences between formulating inorganic sunscreens in O/W and W/O emulsions and their impact on water resistance and formulation stability will be reviewed. The addition of polymers and SPF boosters to increase SPF and water resistance will be presented along with some in vivo SPF testing data.
The work presented will enable formulators to get a head-start to adapt their formulations to the guidelines set forth by the FDA and prepare them to formulate efficiently with inorganic sunscreens.
Dr. Fares started his career in personal care studying the effect of solvents on sunscreen chemicals. His interest in skin drug delivery especially from polymeric matrices grew during his graduate work at Rutgers, where he completed his Ph. D. in Pharmaceutics.
Dr. Fares worked at Block Drug and GlaxoSmithKline where he held positions in research and development in the areas of skincare and oral care. After that, he joined L’Oreal where he held several positions of increasing responsibility leading to AVP of skincare. He is currently the Senior Director of skincare and oral care at Ashland Specialty Ingredients. Dr. Fares is the author of many publications, and patents and made many presentations in national and international meetings in the areas of suncare, skincare, and oral care. Dr Fares sits on the NYSCC scientific committee and has won multiple awards in the area of sun care and polymer chemistry.
Join us for another exciting event for scientists to learn more about the Independent Beauty Movement (Indie) from seed to market. A panel of founders will share their stories and
Join us for another exciting event for scientists to learn more about the Independent Beauty Movement (Indie) from seed to market. A panel of founders will share their stories and discuss new opportunities where the beauty industry, including us scientists, can assist them. Experts from all areas – Google, IBE, ICMAD – will share their knowledge on consumer behavior, business support platforms, and disruptive techniques in operations and discuss what is going right and all challenges to further overcome.
At Door Cost
|Students / Unemployed||$10||$50|
3:00-3:30pm (30 min) – welcome, registration, cocktails
3:30-4:15pm (45 min)- Lauren – Google
4:15-5:15pm – (60 min) Linda, Shannon, Michael/Dave – Founders
5:15-5:30pm – (15 min) quick break (appetizers, cocktails)
5:30-6:15pm – (45 min) Jillian – IBE
6:15- 7:00pm (45 min) Sanjiv – ICMAD
7:00-8:00pm (60 min) dinner and networking
Lauren Ettlinger – email@example.com
Senior Analytical Lead, Beauty- Google
Lauren Ettlinger is a Senior Analytical Lead at Google in New York City working with beauty brands to drive their media strategy based on consumer insights, digital trends and media measurement. She brings years of expertise in insights and trend-spotting across the beauty and personal care industry. She is the resident Google expert on beauty insights and leverages Google’s robust data set to identify new and emerging consumer behavior in prestige skincare, makeup, fragrance and hair categories. Lauren publishes The Google Beauty Insights Report quarterly which highlights top, rising, emerging and declining beauty terms across Google Search & YouTube.
Prior to joining Google, Lauren worked at Nielsen in a variety of roles consulting with several Fortune 500 clients including Disney, NBC Universal and Facebook around cross-platform measurement and consumer behavior. Lauren holds a B.S. from the University of Florida with degrees in Communications and Management. She is an avid reader and a member of the New York Public Library Young Lions. She also serves as a mentor for Big Brothers/Big Sisters NY.
Jillian Wright – firstname.lastname@example.org
Co-Founder, Indie Beauty Media Group
Jillian Wright is the co-founder of Indie Beauty Media Group, producer of Indie Beauty Expo, Uplink Live, Beauty Independent and BeautyX Summit. A skin health expert, Jillian owned and operated Jillian Wright Clinical Skin Spa prior to founding IBMG in 2015. During her tenure there she also launched her eponymous skincare line.
IBE currently produces 3 multiple-day domestic events in New York, Los Angeles, and Dallas, as well as international events in London in 2018 and Berlin in 2019. IBMG’s platform includes Beauty Independent, a digital publication geared towards beauty entrepreneurs, BeautyX Summit series focused on entrepreneurial learning and networking, and Retail Partnerships, with Neiman Marcus, and most recently, with Douglas offering retailers a program to seek, secure and sell differentiated indie beauty collections. Jillian is also the proud recipient of the “Emerging Leader of the Year” award from INNOCOS.
Shannon Vaughn – email@example.com
The Beauty Wellness Brand – KEEPING YOU WELL IN THE MODERN WORLD
In 2011, former model Shannon Vaughn was faced with two significant health crises: the possibility of not having children and an advanced case of PTSD due to living in a turbulent war zone. She dismissed the ideas of surgery or a lifetime of medication and instead sought out alternative holistic healing modalities. Through her journey, Shannon has come to deeply believe in the benefits of wellness via detoxification. In 2014, she set out to source the purest and most potent detox beauty ingredients in the world, to formulate them with the most rigorous research, and to deliver them as lifestyle integrated rituals in the most appealing and accessible forms for modern living…and with that purpose, Pursoma was born.
“I WORKED CLOSELY WITH A NUTRITIONIST AND BIOCHEMIST TO FORMULATE POTENT, EFFECTIVE DETOX TREATMENTS THAT LEFT ME FEELING VIBRANT AND ALIVE AND GAVE ME A SENSE OF INTERNAL PEACE,”
Linda Treska firstname.lastname@example.org
Founder, Pinch of Colour
Pinch of Colour began with a vision: To create a leading-edge beauty company that positively impacts the world through philanthropy, sustainability and community.
Since its inception, Pinch of Colour has been committed to doing things differently. When renowned product formulator Linda Treska dreamed of launching her own brand, she knew that using water in her formulas was not an option. With a childhood marked by water scarcity and a global water crisis growing more dire by the day, Linda sought to make Pinch of Colour the world’s first waterless beauty brand. Driven by a mission to conserve precious water for drinking, Pinch of Colour has changed the beauty landscape to match Linda’s vision: Products that not only perform professionally, but that make a difference through philanthropic initiatives. Today, Pinch of Colour is more than a beauty brand. It is a shift in perspective; a growing community; a movement toward doing things better—and for the greater good. Since its launch in 2016, Pinch of Colour has partnered with Healing Waters Organization, Clean Water for Children, Ekenywa and participated in global events for World Water Day in 2017, 2018 and 2019. Pinch of Colour also partners with Blue Angel Charity, a 501C3 non-profit organization co-founded by Linda to honor her father.
Linda is an experienced Founder with a demonstrated history of working over 22 years in the cosmetics industry. Skilled in Consumer Products, Makeup Artistry, Luxury Goods, Skin Care, Retail and Beauty Industry. Strong business development professional and a global humanitarian.
Michael Putman Michael@elysiancosmetics.nyc
David Rodrigues email@example.com
Michael Putman, President and Co-Fouder, Elysian Cosmetics
David Rodrigues, Co-Founder and CEO, Elysian Cosmetics
Michael Putman and David Rodrigues are makeup artists on a mission. They launched Elysian Cosmetics in 2016 to bring next-generation luxury cosmetics to their clientele. Fusing artistic ingenuity with uncompromising quality, Elysian was born out of the mission to transcend skin prep into an art. Imbued with indulgent textures, clinically-active formulations, and category-defining innovations, the vision has been to launch groundbreaking complexion heroes that elevate the craft of makeup artistry while simultaneously perfecting the skin over time. Always vegan and cruelty-free, Elysian Cosmetics maintains a unique, rigorous standard in ingredient sourcing with a keen focus on raw material bio-compatibility. Founders David Rodrigues and Michael Putman have worked as freelance makeup artists and in-field brand ambassadors for many years, gaining first-hand experience in connecting face-to-face with a diverse range of consumers while getting to understand their needs and expectations out of the beauty products they use.
Sanjiv Mehra – Sanjiv.firstname.lastname@example.org
Vice Chairman, ICMAD
CEO, eos Products
Sanjiv’s career has been almost entirely in the consumer products industry. He co-founded eos Products. Since the launch in 2009, Sanjiv grew eos from an idea to a household name, based on a solid platform of practices and thought that are characteristic of the best CPG companies. Sanjiv was with Unilever’s North American Home & Personal Care Division. With private equity funding, Sanjiv founded Phoenix Brands, with the purchase of a $100+ million portfolio of brands from Unilever and subsequently acquired Colgate’s North American laundry portfolio. Sanjiv’s philosophy is to build operationally sound, accountable organizations that increase value with the quality of their insight, innovation and consumer focus.
Agenda Time Speaker/Title/Company Topic 8:30 - 9:00 Sarah de Szalay, R&D Manager Personal Care RB & Aysel Calkap, Personal Care –
|8:30 – 9:00||Sarah de Szalay, R&D Manager Personal Care RB & Aysel Calkap, Personal Care – Business Development Manager | DSM||Registration & Coffee|
|9:00 – 9:15||Sarah de Szalay, R&D Manager Personal Care RB & Aysel Calkap, Personal Care – Business Development Manager | DSM||Introductions|
|9:15 – 10:00||Peter Larson, Predoctoral Associate at UCONN and The Jackson Laboratory for Genomic Medicine||Engineering the Aging Skin Microbiome|
|10:00 – 10:45||Carine Mainzer, Scientific Support Manager, Silab||Cutaneous microbiota, from healthy to compromised skin : how its presence affects skin physiology|
|10:45 – 11:00||Coffee|
|11:00 – 11:45||DSM||TBC|
|11:45 – 12:30||Patrick Gonry, Safety Assessor, Gobiotics||The influence of cosmetic ingredients on the skin microbiota|
|12:30 – 1:30||Lunch|
|1:30 – 2:15||Steve Schnittger, Vice President – Global Microbiology R&D at Estee Lauder Companies||TBC|
|2:15 – 3:00||Yuli Song, Principle Scientist, P&G Bioscience||Skin Microbiome in Cosmetic Benefit Space|
|3:00 – 3:15||Coffee|
|3:15 – 4:00||Pending||Food Web Speaker|
Event Cost Information
Students / Unemployed
(Thursday) 8:30 AM - 4:00 PM
1700 Harbor Blvd
NYSCC Suppliers’ Day is the most important annual event on the industry calendar in North America and the ONLY event of its calibre in New York City. It attracts thousands
NYSCC Suppliers’ Day is the most important annual event on the industry calendar in North America and the ONLY event of its calibre in New York City. It attracts thousands of the leading players in the market and has become the showcase for the latest innovations and educational programming, on top of being an excellent networking opportunity. As the capital of the worldwide personal care, beauty and fashion industry sectors, New York City is the definitive location and home for this event and will fuel global expansion.
Registration is open!